drugset

drugset / Trial / NCT03674606

Trial of Early Screening Test for Pre-eclampsia and Growth Restriction

NCT03674606 ↗

Phase 4 Completed 546 enrolled University College Dublin National Maternity Hospital, Ireland · collab Perinatal Ireland · collab Royal College of Surgeons, Ireland · collab

RandomizedParallel-groupOpen-labelPrevention

Summary

A study of aspirin use in pregnancy to prevent high blood pressure and growth restriction of the fetus

Timeline

Start: 2014-02-01
Primary completion: 2016-04-13
Completion: 2016-04-13

Publications

Background Mone F, Mulcahy C, McParland P, Stanton A, Culliton M, Downey P, McCormack D, Tully E, Dicker P, Breathnach F, Malone FD, McAuliffe FM. An open-label randomized-controlled trial of low dose aspirin with an early screening test for pre-eclampsia and growth restriction (TEST): Trial protocol. Contemp Clin Trials. 2016 Jul;49:143-8. doi: 10.1016/j.cct.2016.07.003. Epub 2016 Jul 6.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Low dose aspirin	Unknown	75 mg	Oral

Indications